Tuesday, July, 16, 2019 04:59:35

Category: Pharmaceuticals

AstraZeneca phase III lupus-drug trial fails to meet primary goal

AstraZeneca along with its global biologics research and development business, MedImmune, has reportedly announced that the phase III trial for anifrolumab has failed to meet its primary goal. As per trusted sources, the complete evaluation of the data is likely to be conducted after the …

Voluntis & AstraZeneca advance collaboration in the field of oncology

Voluntis, a medical intelligence firm that develops advanced digital therapeutics to enhance medications and medical devices, has reportedly announced to extend its collaboration with AstraZeneca, a multinational pharmaceutical and biopharmaceutical company, in a bid to advance oncology treatment technology. The new agreement states that the …